Drug recall · January 25, 2023
Daptomycin for Injection 350 mg/vial 1 Single-dose vial recall
Why: Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05
- Lots / codes
Lot: R2200232 Exp. 01/2025
- Quantity
- Unknown
- Company
- Accord Healthcare, Inc., Durham, NC
- Distribution
- Nationwide within the United States
- Initiated
- November 29, 2022 · Voluntary: Firm initiated
- Classified
- January 13, 2023
- Reported
- January 25, 2023
- Ended
- February 22, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Daptomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.